Pricing & Market Access Archives · Triangle Insights Group

IRA Part D Redesign – Market Impact & Unintended Consequences

The Inflation Reduction Act’s (IRA) Part D redesign provisions went into effect onJanuary 1, 2025, fundamentally restructuring cost-sharing corridors and upsetting themarketplace. By increasing plan and manufacturer liability, particularly in thecatastrophic phase, this legislation intended to lower the financial burden onbeneficiaries. When the IRA passed, the commonly held hypothesis in the marketplace was that Part […]

Rare Disease in 2026: What Investors Expect and How Companies Must Evolve

In 2026, rare disease investors are prioritizing more than promising science. From commercial readiness to clear revenue pathways, expectations are shifting — and companies must evolve to secure funding and long-term growth.

Forecasting Through an Uncertain Access Environment

Market access uncertainty is reshaping how life sciences companies forecast revenue and plan for launch. As pricing pressure, policy changes, and payer dynamics evolve, commercial teams must adopt more agile, data-driven forecasting strategies to stay competitive.

IRA Part D Redesign – Market Impact & Unintended Consequences

Rare Disease in 2026: What Investors Expect and How Companies Must Evolve

Forecasting Through an Uncertain Access Environment

Get Started